- Report
- October 2024
- 182 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- September 2024
- 133 Pages
Europe
From €3640EUR$4,000USD£3,121GBP
- Report
- November 2023
- 107 Pages
Europe
From €1115EUR$1,225USD£956GBP
€2230EUR$2,450USD£1,912GBP
- Report
- March 2024
- 265 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- July 2023
- 116 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 117 Pages
North America
From €4323EUR$4,750USD£3,706GBP
- Report
- August 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
The Nucleic Acid Sample Preparation market within the context of Laboratory Testing is a rapidly growing sector. It involves the extraction, purification, and concentration of nucleic acids from biological samples for downstream applications such as PCR, sequencing, and gene expression analysis. Sample preparation is a critical step in the laboratory testing process, as it ensures the accuracy and reliability of the results.
The market is driven by the increasing demand for molecular diagnostics, the growing prevalence of infectious diseases, and the increasing adoption of automated sample preparation systems. Additionally, the development of new technologies such as next-generation sequencing and digital PCR is expected to further drive the market.
Notable companies in the Nucleic Acid Sample Preparation market include Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Illumina, Bio-Rad Laboratories, Merck KGaA, Promega Corporation, Takara Bio, and F. Hoffmann-La Roche. Show Less Read more